The CNPV program leveraged to push groundbreaking results of gene therapy treatment. The Food and Drug Administration (FDA) has announced approval for Otarmeni (lunsotogene parvec-cwha), a first-of-its-kind treatment…
Read MoreTreatment
DOJ and DEA Announce Marijuana Rescheduling Actions
Certain medical marijuana products moved to Schedule III as broader review begins. The Justice Department (DOJ) and Drug Enforcement Administration (DEA) announced that FDA-approved products containing marijuana—along with…
Read More
NIH Research Discovers Gene-Editing Option for Disease Treatment
Researchers found a minuscule enzyme that could help advance gene-editing therapy. The National Institutes of Health (NIH) announced the discovery of an enhanced gene-editing system, which can deliver…
Read More
FDA Seeks Public Input on Expedited Review Voucher Pilot Program
The agency has scheduled a hearing and comment period on initiative for faster evaluation of priority therapies. The U.S. Food and Drug Administration (FDA) recently announced a Federal…
Read More
NIH Trial Shows Improved Outcomes for Severe Aplastic Anemia Patients
FDA-approved cord blood therapy demonstrates faster recovery and high survival rates. A clinical trial led by the National Institutes of Health (NIH) reported that an experimental stem cell…
Read More
FDA Approves First Blood Test for Alzheimer’s Diagnosis
The new plasma-based diagnostic tool is intended to improve early detection of Alzheimer’s through a less invasive method. The U.S. Food and Drug Administration (FDA) has cleared the…
Read More
FDA Approves Qfitlia for Hemophilia Treatment
New medication offers less frequent doses to reduce bleeding episodes in patients with Hemophilia A and B. The U.S. Food and Drug Administration has recently approved Qfitlia (fitusiran)…
Read More
FDA Approves New Hemophilia Treatment Hympavzi
Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…
Read More
HHS Announces Funding for HIV Medication Assistance
$1.4 billion allotted to help 560,000 patients afford life-saving drug. The Department of Health and Human Services (HHS) announced over $1.4 billion has been allocated to HIV medication…
Read More
Supreme Court Blocks Title IX Changes
The administration cannot enforce updates to Title IX rule while the case brought by the states is litigated. The U.S. Supreme Court rejected the request from President Biden’s…
Read More